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Abstract ARF6 regulates membrane trafficking between the
plasma membrane and endosomes. We investigated the role of
ARF6 in synaptic vesicle biogenesis as this process occurs both at
the plasma membrane and at endosomes. We used a synaptic
vesicle marker protein, p-selectin-horseradish peroxidase (HRP),
to follow the effects of ARF6 expression on synaptic vesicle
biogenesis in PC12 neuroendocrine cells. Expression of a
constitutively active ARF6 mutant increased, while expression
of a nucleotide-free ARF6 mutant decreased, p-selectin-HRP
levels in the synaptic vesicle peak. These results provide the first
direct evidence for a role for ARF6 in synaptic vesicle
biogenesis. ß 2001 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Synaptic vesicles are a hallmark of neurotransmission; by
fusing with the plasma membrane they allow neurons to com-
municate through release of the neurotransmitter into the
synaptic cleft. The biogenesis of these vesicles requires the
coordination of multiple molecular processes that are not
yet fully understood. New synaptic vesicles can form directly
from the plasma membrane either through a kiss-and-run
mechanism or by a clathrin-mediated process that requires
dynamin and the adapter protein (AP)-2 [1]. Synaptic vesicles
are also generated through an indirect pathway that requires
clathrin-mediated endocytosis from the plasma membrane, as
well as the adapter protein AP-3 and the small GTPase ARF1
for budding from the endosome [2,3]. Both pathways are
thought to be important to maintain neuronal function and
synaptic vesicle integrity, and the mechanisms that target syn-
aptic vesicle proteins in each pathway appear to be di¡erent
[1]. Data from a number of laboratories suggest that individ-
ual synaptic vesicle proteins may be targeted preferentially
through either the direct or the indirect pathway, creating a
heterogeneous population of vesicles with di¡erent ratios of
synaptic vesicle proteins [1]. Furthermore, it is thought that
targeting of di¡erent synaptic vesicle proteins may involve
di¡erent adapter proteins and as yet unknown e¡ectors of
the endocytic pathway.
The ARF family of small GTPases regulates membrane
tra⁄cking pathways throughout the cell. ARF1, the prototyp-
ical member of this family, plays a major role in cargo selec-
tion, the recruitment of coat proteins (including COPI on the
Golgi apparatus, AP-1 on the trans-Golgi network, and AP-3
on endosomes) and vesicle formation. Several years ago, a
new and atypical member of the ARF GTPase family,
ARF6, was demonstrated to play a role in tra⁄cking of pro-
teins between the plasma membrane and endosomes in non-
neuronal cells [4]. Like ARF1, the distribution of ARF6 be-
tween membranes and cytosol appears to be regulated by its
GTPase cycle, but in contrast to ARF1, this process is also
a¡ected by magnesium [5]. While ARF1 is predominantly as-
sociated with Golgi and to a lesser extent with endosomes,
ARF6 is localized to peripheral membranes, including the
plasma membrane and endosomes, and a variety of studies
suggest it may participate in vesicle-mediated transport be-
tween these compartments [4,6]. Expression of ARF6 mutants
has pronounced e¡ects on tra⁄cking of the transferrin recep-
tor (TfR) between the plasma membrane and early endo-
somes. The GTPase-de¢cient mutant Q67L is localized to
the plasma membrane, where it causes an accumulation of
the TfR [7,8]. The T27N mutant, defective in GTP binding,
is associated with the endosomal recycling compartment and,
in some cell types, causes an accumulation of post-endosomal-
coated vesicles [8,9] and blocks the recycling of the TfR from
the endosome to the cell surface [7].
A recent study of ARF6 mutants expressed in the polarized
epithelial MDCK cell line demonstrated that ARF6 is prefer-
entially involved in apical, rather than basolateral, endocyto-
sis [10]. In contrast to results obtained in ¢broblasts, in which
the Q67L and T27N mutants have opposite e¡ects on TfR
tra⁄cking, these studies indicate that both ARF mutants
Q67L and T27N enhance endocytosis from the apical mem-
brane. These results suggest that ARF6 may play a unique
role in protein tra⁄cking in di¡erent cell types and provide a
strong incentive for an independent determination of ARF6
function in neurons and neuroendocrine cells.
Because ARF6 regulates membrane tra⁄cking between two
compartments from which synaptic vesicles form, the plasma
membrane and endosomes, we hypothesized that ARF6 might
play a key role in synaptic vesicle biogenesis. ARF6 is highly
expressed in brain [11] and PC12 cells (Waring, Deans and
Buckley, unpublished data), yet there has been little investi-
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gation into a role for ARF6 in synaptic vesicle formation. We
provide here, the ¢rst direct evidence that ARF6 is involved in
synaptic vesicle biogenesis by demonstrating that expression
of the ARF6 mutants T27N and Q67L in PC12 cells signi¢-
cantly a¡ects the amount of a synaptic vesicle marker protein,
p-selectin-horseradish peroxidase (HRP), targeted to synaptic
vesicles.
2. Materials and methods
2.1. Cell culture and transfection
PC12 cells (ATCC, catalog # 1721-CRL) were cultured and trans-
fected by electroporation as described [12]. Our transfection e⁄ciency
was approximately 10%, as assessed by immuno£uorescent detection
of the FLAG epitope tag on the ARF6 constructs two days after
transfection.
2.2. cDNA constructs
The human ARF6 wild-type, T27N and Q67L C-terminal FLAG-
tagged constructs were obtained from Dr. Victor Hsu [9]. The ARF6
cDNAs were subcloned from the pXS vector into pcDNA3.1+ (Invi-
trogen, Carlsbad, CA, USA), using the EcoRI and XbaI restriction
sites. The p-selectin-HRP cDNA in the vector pRK34 [13] was a gift
from Dr. Daniel Cutler (Medical Research Council, University Col-
lege, London, UK).
2.3. Subcellular fractionation and glycerol velocity gradients
Homogenization of PC12 cells, subcellular fractionation and glyc-
erol velocity gradients were performed as described [12,14]. Eight
fractions were collected and membranes were pelleted by centrifuga-
tion at 85 000 rpm (301 427Ugavg) for 90 min in a Beckman TLA100.4
rotor. Each pellet was resuspended in 400 Wl citrate bu¡er, pH 5.5 (50
mM citrate, 150 mM NaCl), with 0.1% Triton X-100 by shaking for
30 min at 4‡C and spun at 20 000Ug for 10 min in a microcentrifuge
to remove insoluble material.
2.4. Quantitation of p-selectin-HRP targeting
Gradient fractions, homogenate and S2 aliquots were used for a
peroxidase assay as described [13]. The amount of p-selectin-HRP
in synaptic vesicles was determined by adding the peroxidase activity
of all fractions in the synaptic vesicle peak. The speci¢c activity of
p-selectin-HRP in the synaptic vesicle peak was normalized to the
speci¢c activity of p-selectin-HRP in the homogenate or the S2 to
normalize for p-selectin-HRP expression levels. Finally, the normal-
ized p-selectin-HRP in the synaptic vesicle peak of PC12 cells co-
transfected with ARF6 and p-selectin-HRP cDNAs were expressed
as a percent of p-selectin-HRP in the synaptic vesicle peak of PC12
cells transfected with p-selectin-HRP cDNA alone.
2.5. Synaptophysin immunoblotting
Immunoblotting and quantitation of synaptophysin and of FLAG
ARF6, using the murine anti-FLAG M2 antibody (Sigma, St. Louis,
MO, USA), were performed as described [12].
3. Results
To determine whether ARF6 plays a role in synaptic vesicle
biogenesis, we have used a marker protein, p-selectin-HRP, to
quantitatively examine the e¡ect of ARF6 expression on the
formation of synaptic vesicles containing p-selectin-HRP. To
con¢rm the results of Norcott et al. [13], who demonstrated
that p-selectin-HRP is targeted to synaptic vesicles, we ex-
pressed p-selectin-HRP in PC12 cells and analyzed the distri-
bution of peroxidase activity on a glycerol velocity gradient.
The gradient fractions were also assayed for immunoreactivity
to the synaptic vesicle protein synaptophysin by Western blot-
ting to determine the localization of synaptic vesicles in rela-
tion to the peroxidase activity. A peak of synaptophysin im-
munoreactivity was present at 14% glycerol, precisely
corresponding with a peak of peroxidase activity representing
p-selectin-HRP (Fig. 1). This co-localization indicates that
p-selectin-HRP is targeted to synaptic vesicles in PC12 cells,
as described by Norcott et al. [13], and therefore can be used as
a marker for synaptic vesicles to investigate the e¡ects of
ARF6 expression on synaptic vesicle biogenesis. Peroxidase
activity was also present at the top of the gradient; this peak
may represent p-selectin-HRP in small membrane fragments.
We co-expressed p-selectin-HRP with each of the following
ARF6 constructs by transient transfection: wild-type ARF6,
the GTP-binding de¢cient ARF6 T27N mutant, or the
GTPase de¢cient ARF6 Q67L mutant. We ¢rst examined
whether ARF6 expression ^ wild-type or mutant ^ would alter
the size of the synaptic vesicles and therefore, their migration
in the glycerol velocity gradient. Synaptic vesicles containing
p-selectin-HRP migrated at the same position in the gradient
regardless of ARF6 expression (p-selectin-HRP alone = 13.5 þ
0.56% glycerol, wild-type ARF6 = 13.2 þ 0.56%, T27N = 13.5 þ
0.47%, Q67L = 13.3 þ 0.28%). In addition, the position of the
synaptic vesicles in transfected cells (V10% of total), as mea-
sured by the position of p-selectin-HRP in the gradient, was
identical to the position of the synaptic vesicles in all the cells
using the endogenous synaptic vesicle protein synaptophysin
as a marker.
We next examined whether ARF6 expression a¡ects the
amount of p-selectin-HRP in the synaptic vesicle peak on
the glycerol velocity gradient. We co-expressed p-selectin-
HRP with wild-type, T27N or Q67L ARF6. The amount of
p-selectin-HRP in the synaptic vesicle peak was normalized to
the HRP activity in the homogenate or in the S2 (supernatant
loaded onto the gradient) to control for the expression level of
p-selectin-HRP within each experiment. Relative ARF6 ex-
pression levels were determined by immunoblotting for the
C-terminal FLAG tag. Although the expression levels of
each construct were variable from experiment to experiment,
Fig. 1. p-Selectin-HRP is targeted to synaptic vesicles. PC12 cells
were transiently transfected with p-selectin-HRP and a glycerol ve-
locity gradient was run to enrich in synaptic vesicles. Each gradient
fraction was spun at 240 000Ug to pellet all membranes and the re-
suspended pellets were analyzed for synaptophysin immunoreactivity
and peroxidase activity.
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they were all expressed at equivalent levels (data not shown).
Furthermore, the expression levels were not correlated with
any e¡ect on p-selectin-HRP targeting to synaptic vesicles
(data not shown).
The amount of p-selectin-HRP in the synaptic vesicle peak
with ARF6 expression was expressed as a percent of the con-
trol (cells expressing p-selectin-HRP alone). Expression of ei-
ther ARF6 mutant signi¢cantly a¡ected the level of p-selectin-
HRP in the synaptic vesicle peak, while wild-type ARF6 ex-
pression did not alter the amount of p-selectin-HRP in the
synaptic vesicle peak (Fig. 2A). Expression of the GTP-bind-
ing de¢cient ARF6 T27N mutant resulted in a signi¢cant
decrease, while the GTPase-de¢cient ARF6 Q67L mutant
caused a signi¢cant increase in the amount of p-selectin-
HRP in the synaptic vesicle peak normalized to the homoge-
nate.
A di¡erent e¡ect was seen when the amount of p-selectin-
HRP in the synaptic vesicle peak was normalized to the
amount of p-selectin-HRP in the S2 (Fig. 2B). Expression of
wild-type ARF6 or ARF6 T27N did not a¡ect the amount of
p-selectin-HRP in the synaptic vesicle peak, while ARF6
Q67L signi¢cantly increased the level of synaptic vesicle
p-selectin-HRP. While the expression of the ARF6 Q67L mu-
tant increased p-selectin-HRP in the synaptic vesicle peak
when normalized to either the homogenate or S2, the expres-
sion of ARF6 T27N mutant decreased p-selectin-HRP target-
ing to the synaptic vesicle peak only when normalized to the
homogenate. We calculated the speci¢c activity of p-selectin-
HRP in the S2 from cells co-transfected with ARF6 as a
percent of the control. Expression of wild-type ARF6 or
ARF6 Q67L with p-selectin-HRP had no e¡ect, while expres-
sion of ARF6 T27N caused a signi¢cant decrease in the spe-
ci¢c activity of p-selectin-HRP in the S2 (Fig. 3). Expression
of any of the ARF6 constructs, including ARF6 T27N, did
not change the speci¢c activity of p-selectin-HRP in the ho-
mogenate (data not shown), indicating that total cellular
p-selectin-HRP expression levels were not a¡ected by ARF6
expression. This result suggests that ARF6 T27N expression
inhibits the formation of mature synaptic vesicles or causes
mistargeting of p-selectin-HRP.
4. Discussion
We have shown here that the expression of ARF6 mutants
in PC12 cells has a profound e¡ect on the biogenesis of syn-
aptic vesicles. ARF6 could be playing several roles in synaptic
vesicle formation including coat protein recruitment, cargo
selection or vesicle budding. In non-neuronal cells, ARF6
Q67L expression results in a redistribution of the TfR, anFig. 2. Expression of ARF6 T27N and Q67L mutants a¡ects the
amount of p-selectin-HRP in gradient fractions containing synaptic
vesicles. PC12 cells were transiently transfected with p-selectin-HRP
alone (control) or co-transfected with p-selectin-HRP and wild-type
ARF6, ARF6 T27N or ARF6 Q67L. Cellular homogenates were
spun to pellet endosomes and large dense core vesicles, and the re-
sulting supernatant (S2) was separated in a glycerol velocity gra-
dient to enrich in synaptic vesicles. The amount of p-selectin-HRP
in the synaptic vesicle peak, the cellular homogenate, and the S2
was determined by a peroxidase assay. To control for p-selectin-
HRP expression levels the amount of p-selectin-HRP in the synaptic
vesicle peak was normalized to (A) the cellular homogenate or to
(B) the S2 and expressed as a percent of the control þ S.E.M. (A)
*T27N, P6 0.0003, n = 3; **Q67L, P6 0.002, n = 4. (B) *Q67L,
P6 0.005, n = 4, unpaired Student’s t-test.
Fig. 3. Expression of ARF6 T27N decreases the speci¢c activity of
p-selectin-HRP in the S2. Cells were transfected and prepared as in
Fig. 2. The speci¢c activity of p-selectin-HRP in the S2 was calcu-
lated and expressed as a percent of the control. Expression of
ARF6 T27N caused a signi¢cant di¡erence, *P6 0.0107, unpaired
Student’s t-test (n = 3).
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integral membrane protein that recycles constitutively between
the plasma membrane and the endosomal compartment, from
the endosome to the plasma membrane. This result has been
interpreted as the result of a decreased rate of internalization
of TfR from the plasma membrane [7] and/or increased vesicle
budding from the endosome [9] coupled with a relatively rap-
id, but unchanged, fusion rate for these transport vesicles
(t1=2V10 min). The increase in the amount of p-selectin-
HRP seen in the synaptic vesicle peak with ARF6 Q67L ex-
pression is consistent with these results. An increase in the
rate of synaptic vesicle budding from endosomes coupled
with a relatively slow rate of synaptic vesicle fusion
(t1=2V30 min) would lead to an increase in the number of
synaptic vesicles at the steady state. ARF6 could also regulate
synaptic vesicle formation from the plasma membrane. In po-
larized epithelial cells, ARF6 Q67L expression stimulates
clathrin-mediated endocytosis [10], an e¡ect which has not
been observed in non-neuronal cells, suggesting that the func-
tion of ARF6 may be dependent on cell type and cell-speci¢c
e¡ectors and regulators. Interestingly, expression of an ARF6
guanine nucleotide exchange factor (GEF), msec7-1, in Xen-
opus neurons results in an increase in spontaneous synaptic
currents and in the amplitude of evoked currents [15], suggest-
ing that ARF6 expression in neurons can regulate the avail-
ability or number of synaptic vesicles. An alternate explana-
tion of our results is that ARF6 expression regulates the
amount of p-selectin-HRP in each vesicle without a¡ecting
the number of synaptic vesicles. While there is currently no
experimental evidence that suggests ARF6 regulates the rate
of cargo recruitment into coated vesicles, additional experi-
ments will be necessary to determine the relative contributions
of vesicle formation and cargo recruitment to the increased
targeting we have observed.
Expression of ARF6 T27N in PC12 cells produced a de-
crease in the amount of p-selectin-HRP in the synaptic vesicle
peak, as well as a decrease in the speci¢c activity of the S2.
These results suggest that ARF6 T27N expression inhibits
synaptic vesicle formation or causes the mistargeting of p-
selectin-HRP. Expression of ARF6 T27N in COS cells re-
sulted in an accumulation of a novel type of coated endocytic
vesicles [9]. These vesicles contain TfR, but none of the cur-
rently known coat proteins, including coatomer, clathrin or
clathrin-associated proteins (Victor Hsu, personal communi-
cation). In PC12 cells, expression of T27N may result in for-
mation of a synaptic vesicle precursor containing p-selectin
and other synaptic vesicle proteins still enveloped in this novel
coat structure. These coated vesicles sediment at relatively low
velocities (Victor Hsu, personal communication), which could
explain why p-selectin is depleted from the S2 in PC12 cells
expressing the T27N mutant, but not in cells expressing ARF6
Q67L or wild-type ARF6.
Finally, expression of wild-type ARF6 in PC12 cells had no
detectable e¡ect on synaptic vesicle biogenesis. Since the
GEFs for most small G proteins are thought to be rate-limit-
ing, simply increasing the levels of wild-type ARF6 above
endogenous amounts would be expected to have little or no
e¡ect on ARF6 function.
In addition to ARF6, another ARF family member is im-
portant for synaptic vesicle biogenesis in PC12 cells. Faundez
et al. [2] demonstrated that formation of synaptic vesicles
containing the synaptic vesicle protein synaptobrevin is sensi-
tive both in vitro and in vivo to inhibitors of ARF1, and
p-selectin targeting to synaptic vesicles is almost completely
inhibited by treatment of PC12 cells with Brefeldin A, a fun-
gal metabolite that speci¢cally inhibits ARF1 [16]. Why would
two distinct ARF proteins be involved in the same process?
One possibility is that ARF1 and ARF6 regulate distinct steps
in synaptic vesicle formation through di¡erent e¡ectors.
ARF1, for example, might regulate coat recruitment, while
ARF6 regulates budding. Another possibility is that ARF1
and ARF6 regulate the formation of di¡erent types of synap-
tic vesicles, perhaps containing di¡erent ratios of synaptic
vesicle proteins.
We have shown that expression of ARF6 mutants in PC12
cells a¡ects the biogenesis of synaptic vesicles. The mecha-
nisms by which ARF6 activation regulates coat recruitment,
which itself can determine cargo selection, and/or vesicle bud-
ding, have yet to be determined. Of particular interest for
future experiments is the role of ARF6 e¡ectors, including
adapter proteins and phospholipases, and regulators such as
ARF6 GEFs and GAPs (GTPase activating proteins) in syn-
aptic vesicle formation.
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